KR890014452A - 네오펜틸에스테르유도체, 그 제조방법 및 그의 의약에의 이용 - Google Patents

네오펜틸에스테르유도체, 그 제조방법 및 그의 의약에의 이용 Download PDF

Info

Publication number
KR890014452A
KR890014452A KR1019890003844A KR890003844A KR890014452A KR 890014452 A KR890014452 A KR 890014452A KR 1019890003844 A KR1019890003844 A KR 1019890003844A KR 890003844 A KR890003844 A KR 890003844A KR 890014452 A KR890014452 A KR 890014452A
Authority
KR
South Korea
Prior art keywords
neopentyl ester
residue
hydrogen
cooch
chemical formula
Prior art date
Application number
KR1019890003844A
Other languages
English (en)
Inventor
메츠 군터
로이힐레 쿠르트
에르트만 만프레트
Original Assignee
아돌프 메르클레
메르클레 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아돌프 메르클레, 메르클레 게엠베하 filed Critical 아돌프 메르클레
Publication of KR890014452A publication Critical patent/KR890014452A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • C07C229/58—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position having the nitrogen atom of at least one of the amino groups further bound to a carbon atom of a six-membered aromatic ring, e.g. N-phenyl-anthranilic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

내용 없음.

Description

네오펜틸에스테르유도체, 그 제조방법 및 그의 의약에의 이용
내용없음

Claims (13)

  1. 일반식(I)
    의 네오펜틸에스테르.
    상기식에서, Ar-CO는 디클로페낙, 로나졸락, 인도메타신, 플루페남산, 플루르비프로펜 및 이브프로펜, 케토프로펜, 나트록센 및 스푸로펜의 라세미 및 광학 활성체로 구성된 군으로 부터 선택된 항 류마티즘에 유효한 산의 잔기를 표시하고, X는 기 CH2또는 CH2COOCH2를 표시하고, R은 수소 또는 히드록시기를 표시한다.
  2. 제1항에 있어서, Ar-CO는 디클로페낙의 잔기이고, X는 기 CH2이고, R은 수소인 화학식
    의 디클로페낙의 네오펜틸에스테르.
  3. 제1항에 있어서, Ar-CO는 나프록센의 잔기이고, X는 CH2COOCH2이고, R은 수소인 화학식
    의 나프록센의 네오펜틸에스테르.
  4. 제1항에 있어서, Ar-CO는 플루페남산의 잔기이고, X는 CH2이고, R은 OH인 화학식
    의 플루페남산의 네오펜틸에스테르.
  5. 제1항에 있어서, Ar-CO는 로나졸락의 잔기이고, X는 CH2COOCH2이고, R은 수소인 화학식
    의 로나졸락의 네오펜틸에스테르.
  6. 제1항에 있어서, Ar-CO는 인도메타신의 잔기이고, X는 CH2COOCH2이고, R은 수소인 화학식
    의 인도메타신의 네오펜틸에스테르.
  7. 제1항에 있어서, Ar-CO는 수프로펜의 잔기이고, X는 CH2COOCH2이고, R은 수소인 화학식.
    의 수프로펜의 네오펜틸에스테르.
  8. (a) 상승된 온도에서, 경우에 따라서는 불활성유기용제중에서 그리고 반응수침강하 산 촉매의 존재하에서 제1항에서 지정한 산들중의 하나를 다음 일반식(II)
    (X 및 R은 제1항에서 정의한 바와 같음)의 알코올로 에스테르화시키거나 또는 (b) 상승된 온도에서 적합한 유기용제중에서 제1항에서 지정한 산의 금속염을 일반식(III)
    (Hal은 염소, 요오드 또는 브롬을 의미하고 R 및 X는 제1항에서의 정의와 같음)의 할로겐 유도체와 반응시킴을 특징으로 하는, 제1항에 의한 네오펜틸에스테르를 제조하는 방법.
  9. 제8항에 있어서, 80 내지 120℃의 온도에서 반응수를 공비 분리함이 없이 제1항에서 지정한 산들중의 하나를 일반식(II)의 알코올과 반응시키고, 과잉의 알코올을 불활성 유기용제를 가함으로써 침전시키거나 진공증류에 의해 제거되고, 수득된 조 에스테르를 결정화시키거나 액상물의 경우에는 진공 플래쉬 증류장치내에서 증류시키고 및/또는 중압 액체 크로마토그래피에 의해 정제하는 것을 특징으로 하는 방법.
  10. 제9항에 있어서, 산과 알코올을 1:(8~15), 바람직하게는 1:(10.5~12)의 몰비로 사용하는 것을 특징으로하는 방법.
  11. 제1항 내지 7항중의 어느하나에 의한 네오펜틸에스테르와 통상적 갈렌식 보조제를 함유하는 의약.
  12. 제11항에 있어서, 10 내지 40%의 농도의 디메틸술폭시드 및 경우에 따라서는 5 내지 10%의 요소를 추가로 함유하는 피부용 의약.
  13. 류마티즘 동형단의 질환을 치료하기위한 경구, 직장경유 및 경피 의약을 제조하는데 사용하는 것을 특징으로 하는 제1항 내지 7항중의 어느하나에 의한 네오펜틸에스테르.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890003844A 1988-03-31 1989-03-27 네오펜틸에스테르유도체, 그 제조방법 및 그의 의약에의 이용 KR890014452A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3811120A DE3811120A1 (de) 1988-03-31 1988-03-31 Neopentylesterderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DEP3811120.9 1988-03-31

Publications (1)

Publication Number Publication Date
KR890014452A true KR890014452A (ko) 1989-10-23

Family

ID=6351241

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890003844A KR890014452A (ko) 1988-03-31 1989-03-27 네오펜틸에스테르유도체, 그 제조방법 및 그의 의약에의 이용

Country Status (5)

Country Link
EP (1) EP0335164A3 (ko)
JP (1) JPH0215048A (ko)
KR (1) KR890014452A (ko)
DE (1) DE3811120A1 (ko)
FI (1) FI891411A (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017185A1 (en) * 1991-03-29 1992-10-15 University Of Florida Targeted drug delivery via mixed phosphate derivatives
JPH04135745U (ja) * 1991-06-10 1992-12-17 日本アビオニクス株式会社 背面投射型マルチ・スクリ−ン
ES2065242B1 (es) * 1992-12-14 1995-10-01 Lepori Farma Sa Derivados del acido fenilacetico, procedimiento para su obtencion y utilizacion correspondiente.
US6207700B1 (en) 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6762182B1 (en) 1999-01-07 2004-07-13 Vanderbilt University Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
US6306890B1 (en) 1999-08-30 2001-10-23 Vanderbilt University Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
DE10029077A1 (de) * 2000-06-13 2001-12-20 Bayer Ag Thiazolylsubstituierte Heterocyclen
US7632866B2 (en) 2002-10-21 2009-12-15 Ramot At Tel Aviv University Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
JP2007534702A (ja) 2004-04-26 2007-11-29 バンダービルト・ユニバーシティ 胃腸毒性の低い治療薬としてのインドール酢酸、及びインデン酢酸誘導体
EP2040699A4 (en) 2006-06-19 2013-03-13 Vanderbilt University Medical Ct METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND THERAPEUTIC TARGETING OF COX-2
WO2009037705A2 (en) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation
CN101868443A (zh) 2007-09-20 2010-10-20 特拉维夫大学拉莫特有限公司 N-苯基邻氨基苯甲酸衍生物及其用途
WO2013059245A1 (en) 2011-10-17 2013-04-25 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA701191B (en) * 1969-03-24 1971-09-29 Syntex Corp 2-(6-substituted-2'-naphthyl)acetic acid esters and process for producing same

Also Published As

Publication number Publication date
EP0335164A2 (de) 1989-10-04
EP0335164A3 (de) 1991-03-20
FI891411A0 (fi) 1989-03-23
FI891411A (fi) 1989-10-01
JPH0215048A (ja) 1990-01-18
DE3811120A1 (de) 1989-10-12

Similar Documents

Publication Publication Date Title
KR890014452A (ko) 네오펜틸에스테르유도체, 그 제조방법 및 그의 의약에의 이용
EP0112130B1 (en) Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids, their preparation and use
RU95112575A (ru) Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция
FR2650587B1 (fr) Procede de preparation en continu d'acrylates legers
BE851080A (fr) Procede de purification d'eaux contenant des produits organiques par extraction desdits produits organiques au moyen d'un solvant immobilise
US5283372A (en) Preparation of purified optical isomers of desflurane
JPH0417937B2 (ko)
Fleš et al. The Correlation of Configurations of Chloroamphenicol and D-Serine
US5097064A (en) Process for preparing optically active 2-arylpropionic acids
US4252624A (en) Bromination of m-ethyldiphenyl ether
JP2600354B2 (ja) ラセミ菊酸類の製造方法
JP2591111B2 (ja) 光学活性α−オキシ酸エステルの立体配置を反転させる方法
JP2573982B2 (ja) １−アセトキシエチル２−（２−フルオロ−４−ビフェニリル）プロピオネートを製造する方法
JPH0768234B2 (ja) コウジ酸エステル誘導体
JPH1143467A (ja) 脂肪酸グリセライド誘導体及びグリセライド誘導体、並びにそれらの製造方法
JPS5555135A (en) Preparation of d-2-(6-methoxy-2-naphthyl)-propionic acid
JPH01301640A (ja) α−置換酢酸の精製方法
EP0153203A1 (fr) Acides gras ramifiés en C10 à C20 utiles en tant que médicaments, et leur procédé de préparation
JPS63154647A (ja) エステル誘導体の製法
KR890014105A (ko) 디에틸렌글리콜모노에스테르, 그 제조방법 및 그의 의약에의 이용
FR2547726A1 (fr) Acide 2-(4-biphenylyl)-4-hexenoique et ses derives ayant une activite anti-inflammatoire
JPS59108734A (ja) グルタルアルデヒドの製造方法
JPS5536429A (en) Preparation of (+)-2-(6-methoxy-2-naphthyl)propionic acid and its intermediate
JP2918029B2 (ja) ラセミアルコールの製造法
CN1144092A (zh) 可释放一氧化氮的新型非类固醇类抗炎药、它们的制备方法和用途

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid